Your browser doesn't support javascript.
loading
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.
Copland, Mhairi; Ariti, Cono; Thomas, Ian F; Upton, Laura; Sydenham, Mia; Mehta, Priyanka; Islam, Shahid; Kjeldsen, Lars; Burnett, Alan K; Hills, Robert K; Russell, Nigel; Dennis, Mike.
Afiliação
  • Copland M; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Ariti C; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Thomas IF; Oxon Epidemiology, Madrid, Spain.
  • Upton L; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Sydenham M; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Mehta P; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Islam S; University Hospitals of Bristol and Weston NHS Trust, Bristol, UK.
  • Kjeldsen L; Department of Haematology, Waikato Hospital, Hamilton, New Zealand.
  • Burnett AK; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hills RK; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Russell N; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Dennis M; Guy's and St Thomas' NHS Trust, London, UK.
Br J Haematol ; 204(3): 871-876, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38016651

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Citarabina Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Citarabina Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article